Page last updated: 2024-11-06

prednisolone and Fibrous Dysplasia of Bone

prednisolone has been researched along with Fibrous Dysplasia of Bone in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Fibrous Dysplasia of Bone: A disease of bone marked by thinning of the cortex by fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. Only one bone may be involved (FIBROUS DYSPLASIA, MONOSTOTIC) or several (FIBROUS DYSPLASIA, POLYOSTOTIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohrs, U1
Hauswaldt, C1
Hunstein, W1

Other Studies

1 other study available for prednisolone and Fibrous Dysplasia of Bone

ArticleYear
[The modification of experimental bone marrow fibrosis after repeated administration of foreign proteins by antiphlogistics and prednisolone acetate].
    Blut, 1969, Volume: 19, Issue:7

    Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Blood Cell Count; Blood Platelets; Body Weight; Bone

1969